Company Announcements

RNS Number : 8613S
JPMorgan European Discovery Trust
18 July 2022
 

 

LONDON STOCK EXCHANGE ANNOUNCEMENT

 

JPMORGAN EUROPEAN DISCOVERY TRUST PLC

 

RESULTS OF 2022 ANNUAL GENERAL MEETING

 

 

Legal Entity Identifier: 54930049CEWDI46Y3U28

Information disclosed in accordance with LR 9.6.18

 

Results of Annual General Meeting

 

Following the Annual General Meeting of the Company, which was held today, the Board is pleased to announce that all of the Ordinary Resolutions put to shareholders were voted on by Poll and passed. In addition, the following items of Special Business were also voted on by Poll and passed. These were:

 

i)          allow the Directors of the Company to exercise all powers of the Company to allot shares in the Company up to an aggregate nominal amount of £393,687 representing approximately 5% of the Company's issued ordinary share capital as at the date of the passing of the resolution;

 

ii)         allow the disapplication of pre-emption rights on the allotment of new ordinary shares;

 

iii)        allow the Company to make market purchases of up to 14.99% of the Company's issued ordinary share capital as at the date of the passing of the resolution, and

 

The full text of all the resolutions can be found in the Notice of Annual General Meeting contained in the Annual Report and Financial Statements which is available for viewing at the National Storage Mechanism which can be located at https://data.fca.org.uk/#/nsm/nationalstoragemechanism as well as from the Company's website, www.jpmeuropeandiscovery.co.uk

 

A summary of the votes received will shortly be available on the Company's website, www.jpmeuropeandiscovery.co.uk

 

18th July 2022

 

For further information, please contact:

 

Priyanka Vijay Anand

For and on behalf of

JPMorgan Funds Limited - Company Secretary

020 7742 4000

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RAGSFFFLAEESEEW